Cargando…

Ambulante Betreuung onkologischer Patienten in palliativer Behandlungssituation und ihrer Angehörigen in der COVID-19-Pandemie: Erfahrungen, Herausforderungen und Lösungsansätze niedergelassener Onkologen

BACKGROUND: During the current pandemic situation, the public health care system must ensure the ongoing provision of regular medical care as well as the treatment of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infected patients. Resident oncologists and their practices are equ...

Descripción completa

Detalles Bibliográficos
Autores principales: Weber, Jan P., Tielker, Jannik M., Kamandi, Nilab, Simon, Steffen T., Bausewein, Claudia, Stiel, Stephanie, Schneider, Nils
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134804/
https://www.ncbi.nlm.nih.gov/pubmed/34031624
http://dx.doi.org/10.1007/s00761-021-00974-z
Descripción
Sumario:BACKGROUND: During the current pandemic situation, the public health care system must ensure the ongoing provision of regular medical care as well as the treatment of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infected patients. Resident oncologists and their practices are equally affected. OBJECTIVES: The study examines resident oncologists’ challenges, experiences and approaches in the delivery of care for oncological patients receiving palliative treatment and their relatives during the pandemic. Findings will support future pandemic preparedness for cancer treatment in outpatients. MATERIALS AND METHODS: Content analyses of 13 guideline-based telephone interviews with resident oncologists. RESULTS: Solid local networks, staff and structural rearrangements and infection control within offices helped oncologists maintaining quality of care. Required treatments have been continued. The interrupted information flow towards patients’ relatives and catching up on previously postponed primary, control or follow-up consultations have been reported as a challenge. Other issues have been linked to suspected SARS-CoV‑2 infection in patients and staff. The lack of information, temporal inaccessibility of health care authorities and physicians’ associations, and additional costs for infection control material caused further problems. CONCLUSIONS: Due to the firmly implemented infection control and the re-organisation of facilities and staff, oncologists have been able to maintain treatment and care for cancer patients and their relatives. Hygiene procedures proved to work well and might be re-activated. An increased use of digital applications for treatment monitoring might be considered. Furthermore, solutions to meet additional financial and personnel demands caused by infection control must be identified. The design of suitable concepts for the prevention of health-related hazards due to visiting bans for relatives and therapeutic staff such as physio- and occupational therapists is inevitable.